Posted on 11/17/16
Aclaris Announces Proposed Public Offering of Common Stock
MALVERN, Pa., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that it intends to offer and sell, . . .
Posted on 11/16/16
Inovio Wins Deloitte’s “Fast 500” Growth Award
PLYMOUTH MEETING, Pa., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced it ranked No. 107 on Deloitte’s Technology Fast 500™, a ranking . . .
Posted on 11/16/16
MTBC Named in Deloitte's 2016 Technology Fast 500
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), one of the fastest growing technology companies in the U.S., today announced that it has been named in Deloitte's Technology Fast . . .
Posted on 11/16/16
Celgene's (CELG) Management Presents at Stifel Nicolaus Weisel Healthcare Conference 2016 - Earnings Call Transcript
Celgene Corporation (NASDAQ:CELG)Company Conference PresentationNovember 15, 2016, 08:45 AM ETExecutivesScott Smith - President, Global I&IAnalystsKatherine Breedis - Stifel, Nicolaus & Co., Inc.OperatorQuestion-and-Answer SessionQ - Katherine BreedisAll . . .
Posted on 11/16/16
Teva Pharmaceutical Industries (TEVA) Erez Vigodman on Q3 2016 Results - Earnings Call Transcript
Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)Q3 2016 Earnings Conference CallNovember 15, 2016 08:00 AM ETExecutivesKevin Mannix - SVP, IRErez Vigodman - CEOEyal Desheh - CFOSiggi Olafsson . . .
Posted on 11/16/16
Merck KGaA's (MKGAF) CEO Walter Galinat on Q3 2016 Results - Earnings Call Transcript
Merck KGaA (OTCPK:MKGAF) Q3 2016 Earnings Conference Call October 16, 2014 10:00 AM ETExecutivesConstantin Fest – Head-Investor RelationsMarcus Kuhnert – Chief Financial OfficerWalter Galinat – Chief . . .
Posted on 11/16/16
Here's How Bed Bath & Beyond Is Looking To Increase Store Traffic
Reports suggest that Bed Bath & Beyond (NASDAQ:BBBY) will serve wine and beer to its customers at its new 120,000 square foot store with a restaurant, . . .
Posted on 11/16/16
Better Buy: Johnson & Johnson vs. Merck
If you owned shares of either Johnson & Johnson (NYSE:JNJ) or Merck (NYSE:MRK) over the last five years, you're likely a happy camper. Both stocks are . . .
Posted on 11/16/16
Go for It, Pfizer -- Sell Your Consumer Healthcare Business
If at first you don't sell or spin off, try, try again.In September, Pfizer (NYSE:PFE) announced that it had decided not to split its legacy drug . . .
Posted on 11/16/16
Better Buy: Biogen Inc. vs. Celgene Corporation
This year might have started off poorly for biotech stocks, but things have certainly changed after the surprising election results. Two of the biggest biotechs around, . . .
Posted on 11/16/16
Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough
It's been a tough year for generic drugmakers. Teva Pharmaceutical (NYSE:TEVA) is no exception, with its stock down nearly 40% year to date. Teva announced its . . .
Posted on 11/15/16
FamilyWize‘s emRxcel Automates Patient Prescription Savings Program Through Physician EMR Systems
FamilyWize announced today the launch of emRxcel®, a proprietary product that integrates its prescription drug savings program with electronic medical records (EMRs) to help patients save . . .
Posted on 11/15/16
Matinas BioPharma Reports 2016 Third Quarter Financial Results and Provides Corporate Update
BEDMINSTER, N.J., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.(OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum . . .
Posted on 11/15/16
Why PTC Therapeutics Is Soaring Again
IMAGE SOURCE: GETTY IMAGES.What happenedInvestors in PTC Therapeutics (NASDAQ:PTCT), a biotech focused on rare diseases, are having a pleasant start to the trading week. Shares are . . .
Posted on 11/16/16
A Video Conversation with Frank Powers, Founding Partner of Elevate Healthcare Marketing
Brought to you by Newmark Grubb Knight Frank
Posted on 11/14/16
Bayshore Pharmaceuticals Announces Launch of Carvedilol Tablets
In collaboration with Beximco Pharmaceuticals Ltd. (Dhaka, Bangladesh), Bayshore Pharmaceuticals announces that it has commercially launched Carvedilol tablets (3.125 mg, 6.25 mg, 12.5 mg, 25 mg). . . .
Posted on 11/14/16
Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold
Juno Therapeutics (NASDAQ:JUNO) announced its third-quarter earnings results on Wednesday after the market closed. Shares of the biotech were already soaring in response to the outcome . . .
Posted on 11/11/16
Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday
What happenedShares of Allergan (NYSE:AGN), Horizon Pharma plc (NASDAQ:HZNP), and Pfizer(NYSE:PFE) all surged higher yesterday on the news that Donald Trump would become the next president . . .
Posted on 11/10/16
Recro Pharma Reports Third Quarter 2016 Financial Results
MALVERN, Pa., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care . . .
Posted on 11/10/16
Lithium Stock Investors: FMC Corp. Kicked Off the Industry's Q3 Earnings Season With a Bang
FMC Corp.(NYSE:FMC) kicked off the third-quarter earnings season for the big lithium players on Nov. 2 by posting strong adjusted earnings growth, driven in part by . . .
Posted on 11/10/16
Why Celldex Therapeutics, Inc. Stock Tumbled 22% in October
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) a clinical-stage biotech developing targeted cancer therapies, fell 22% in October, according to data from S&P . . .
Posted on 11/10/16
Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.
Your time horizon matters when picking a stock.Gilead Sciences (NASDAQ:GILD), for example, gave investors five times the returns of Pfizer (NYSE:PFE) over the past five years. . . .
Posted on 11/10/16
Trump's Win Is Causing a Tremendous Sell-Off in Hospital Stocks
IMAGE SOURCE: GETTY IMAGES.What happenedAfter Americans elected Donald Trump President, shares in HCA Holdings (NYSE:HCA), Community Health Systems (NYSE:CYH), and Tenet Healthcare Corp. (NYSE:THC) are falling . . .
Posted on 11/10/16
Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?
Pharma stocks, so far, are reacting positively to the news the Donald Trump has upended Hillary Clinton to become the 45th President of the United States . . .
Posted on 11/9/16
Eagle Pharmaceuticals Reports Third Quarter 2016 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three- and nine-months ended September 30, 2016. Highlights of and subsequent to . . .
Philadelphia
